Interpreting results from biomarker-guided clinical trials: avoiding “negative” or “failed” terminology
Saved in:
| Main Authors: | Nurulamin M. Noor, Haiyan Zheng, David S. Robertson, Joshua Savage, Christina Yap, Andrea L. Jorgensen, James M. S. Wason, on behalf of the MRC-NIHR Trial Methodology Research Partnership (TMRP) Precision Medicine Working Group |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12916-025-04035-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rheumatoid Arthritis Prevention: catalysing PlatfORm Trial delivery (RAPPORT)
by: Michelle Bardgett, et al.
Published: (2025-02-01) -
New insights into biomarkers and risk stratification to predict hepatocellular cancer
by: Katrina Li, et al.
Published: (2025-04-01) -
Psychotic relapse prediction via biomarker monitoring: a systematic review
by: Alexandros Smyrnis, et al.
Published: (2024-12-01) -
Biomarkers in spinal muscular atrophy
by: Liping Yan, et al.
Published: (2025-07-01) -
Precision Medicine in Age-Related Macular Degeneration: Current Approaches and Future Directions
by: Mehrdad Motamed Shariati
Published: (2025-03-01)